Dynamic perfusion MRI: Capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease

Journal of Magnetic Resonance Imaging

Volumn 28, Issue 4, 2008, Pages 887-899

  Ohno, Yoshiharu ^a   Koyama, Hisanobu ^a   Nogami, Munenobu ^a,b   Takenaka, Daisuke ^a   Matsumoto, Sumiaki ^a   Onishi, Yumiko ^a,b   Matsumoto, Keiko ^a,c   Murase, Kenya ^d   Sugimura, Kazuro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

CT; Hypertension; Interstitial lung disease; Lung; MR; Perfusion

Indexed keywords

CARBON MONOXIDE; GADODIAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HUMAN; LUNG BLOOD FLOW; LUNG BLOOD VOLUME; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG PERFUSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADULT; AGED; ANALYSIS OF VARIANCE; CONNECTIVE TISSUE DISEASES; CONTRAST MEDIA; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GADOLINIUM DTPA; HUMANS; HYPERTENSION, PULMONARY; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 53549097906     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21550     Document Type: Article

References (43)

1. Hoeper MM. Pulmonary hypertension in collagen vascular disease. Eur Respir J 2002;19:571-576.
2. Yamane K, Ihn H, Asano Y, et al. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology 2000;39:1269-1271.
3. Murata I, Takenaka K, Yoshinoya S, et al. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients. Chest 1997;111:36-43.
4. Hoffman RW, Greidinger EL. Mixed connective tissue disease. Curr Opin Rheumatol 2000;12:386-390.
5. Yousem SA. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 1990;21:467-474.
6. Edwards PD, Bull RK, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol 1998;71:1018-1020.
7. Haimovici JB, Trotman-Dickenson B, Halpern EF, et al. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program. Acad Radiol 1997;4:327-334.
8. Mousseaux E, Tasu JP, Jolivet O, Simonneau G, Bittoun J, Gaux JC. Pulmonary arterial resistance: noninvasive measurement with indexes of pulmonary flow estimated at velocity-encoded MR imaging - preliminary experience. Radiology 1999;212:896-902.
9. Laffon E, Laurent F, Bernard V, De Boucaud L, Ducassou D, Marthan R. Noninvasive assessment of pulmonary arterial hypertension by MR phase-mapping method. J Appl Physiol 2001;90:2197-2202.
10. Worsley DF, Palevsky HI, Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med 1994;35:793-796.
11. Fukuchi K, Hayashida K, Nakanishi N, et al. Quantitative analysis of lung perfusion in patients with primary pulmonary hypertension. J Nucl Med 2002;43:757-761.
12. Ohno Y, Hatabu H, Takenaka D, Adachi S, Hirota S, Sugimura K. Contrast-enhanced MR perfusion imaging and MR angiography: utility for management of pulmonary arteriovenous malformations for embolotherapy. Eur J Radiol 2002;41:136-146.
13. Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. Radiology 2002;224:503-511.
14. Ohno Y, Nogami M, Higashino T, et al. Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy. J Magn Reson Imaging 2005;21:775-783.
15. Ohno Y, Hatabu H, Higashino T, et al. Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer. Am J Roentgenol 2004;182: 73-78.
16. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 2004;20:353-365.
17. Ohno Y, Hatabu H, Murase K, et al. Primary pulmonary hypertension: 3D dynamic perfusion MRI for quantitative analysis of regional pulmonary perfusion. Am J Roentgenol 2007;188:48-56.
18. Ley S, Mereles D, Risse F, et al. Quantitative 3D pulmonary MR-perfusion in patients with pulmonary arterial hypertension: correlation with invasive pressure measurements. Eur J Radiol 2007; 61:251-255.
19. Ohno Y, Koyama H, Nogami M, et al. Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. Am J Roentgenol 2007;189:400-408.
20. Nikolaou K, Schoenberg SO, Brix G, et al. Quantification of pulmonary blood flow and volume in healthy volunteers by dynamic contrast-enhanced magnetic resonance imaging using a parallel imaging technique. Invest Radiol 2004;39:537-545.
21. Fink C, Puderbach M, Ley S, et al. Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels. Invest Radiol 2004;39:143-148.
22. Ohno Y, Murase K, Higashino T, et al. Assessment of bolus injection protocol with appropriate concentration for quantitative assessment of pulmonary perfusion by dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 2007;25:55-65.
23. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:S40-S47.
24. Rubin LJ: American College of Chest Physicians. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:S4-6.
25. [No authors listed.] Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590.
26. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205.
27. Wollheim FA. Classification of systemic sclerosis. Visions and reality. Rheumatology 2005;44:1212-1216.
28. Kasukawa R. Mixed connective tissue disease. Intern Med 1999; 38:386-393.
29. Walker JG, Pope J, Baron M, et al. The development of systemic sclerosis classification criteria. Clin Rheumatol 2007;26:1401-1409.
30. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6: 731-744.
31. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn Reson Med 1996;36:715-725.
32. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996;36: 726-736.
33. Murase K, Shinohara M, Yamazaki Y. Accuracy of deconvolution analysis based on singular value decomposition for quantification of cerebral blood flow using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Phys Med Biol 2001;46:3147-3159.
34. Murase K, Kikuchi K, Miki H, Shimizu T, Ikezoe J. Determination of arterial input function using fuzzy clustering for quantification of cerebral blood flow with dynamic susceptibility contrast-enhanced MR imaging. J Magn Reson Imaging 2001;13:797-806.
35. American Thoracic Society. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987;136:1285-1298.
36. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-1218.
37. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA: Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-184.
38. Camiciottoli G, Orlandi I, Bartolucci M, et al. Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 2007;131:672-681.
39. Weinberger SE. Overview of the interstitial lung disease. In: Weinberger SE, ed. Principles of pulmonary medicine, 3rd ed. Philadelphia: W.B. Saunders; 1998. p 130-140.
40. Weinberger SE. Pulmonary hypertension. In: Weinberger SE, ed. Principles of pulmonary medicine. 3rd ed. Philadelphia: W.B. Saunders; 1998. p 184-193.
41. Magliano M, Isenberg DA, Hillson J. Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 2002;46:1997-2009.
42. Proudman SM, Stevens WM, Sahhar J, Celermajer D. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J 2007;37:485-494.
43. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-547.